175 related articles for article (PubMed ID: 22972806)
1. Summary of the evidence of breast cancer service screening outcomes in Europe and first estimate of the benefit and harm balance sheet.
Paci E;
J Med Screen; 2012; 19 Suppl 1():5-13. PubMed ID: 22972806
[TBL] [Abstract][Full Text] [Related]
2. European breast cancer service screening outcomes: a first balance sheet of the benefits and harms.
Paci E; Broeders M; Hofvind S; Puliti D; Duffy SW;
Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1159-63. PubMed ID: 24991022
[TBL] [Abstract][Full Text] [Related]
3. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer mortality in mammographic screening in Europe: a review of incidence-based mortality studies.
Njor S; Nyström L; Moss S; Paci E; Broeders M; Segnan N; Lynge E;
J Med Screen; 2012; 19 Suppl 1():33-41. PubMed ID: 22972809
[TBL] [Abstract][Full Text] [Related]
5. False-positive results in mammographic screening for breast cancer in Europe: a literature review and survey of service screening programmes.
Hofvind S; Ponti A; Patnick J; Ascunce N; Njor S; Broeders M; Giordano L; Frigerio A; Törnberg S; ; Van Hal G; Martens P; Májek O; Danes J; von Euler-Chelpin M; Aasmaa A; Anttila A; Becker N; Péntek Z; Budai A; Mádai S; Fitzpatrick P; Mooney T; Zappa M; Ventura L; Scharpantgen A; Hofvind S; Seroczynski P; Morais A; Rodrigues V; Bento MJ; Gomes de Carvalho J; Natal C; Prieto M; Sánchez-Contador Escudero C; Zubizarreta Alberti R; Fernández Llanes SB; Ascunce N; Ederra Sanza M; Sarriugarte Irigoien G; Salas Trejo D; Ibáñez Cabanell J; Wiege M; Ohlsson G; Törnberg S; Korzeniewska M; de Wolf C; Fracheboud J; Patnick J; Lancucki L; Ducarroz S; Suonio E
J Med Screen; 2012; 19 Suppl 1():57-66. PubMed ID: 22972811
[TBL] [Abstract][Full Text] [Related]
6. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
[TBL] [Abstract][Full Text] [Related]
7. The cumulative risk of a false-positive recall in the Norwegian Breast Cancer Screening Program.
Hofvind S; Thoresen S; Tretli S
Cancer; 2004 Oct; 101(7):1501-7. PubMed ID: 15378474
[TBL] [Abstract][Full Text] [Related]
8. The impact of mammographic screening on breast cancer mortality in Europe: a review of trend studies.
Moss SM; Nyström L; Jonsson H; Paci E; Lynge E; Njor S; Broeders M;
J Med Screen; 2012; 19 Suppl 1():26-32. PubMed ID: 22972808
[TBL] [Abstract][Full Text] [Related]
9. Service screening with mammography in Northern Sweden: effects on breast cancer mortality - an update.
Jonsson H; Bordás P; Wallin H; Nyström L; Lenner P
J Med Screen; 2007; 14(2):87-93. PubMed ID: 17626708
[TBL] [Abstract][Full Text] [Related]
10. First report of introducing population-based breast cancer screening in Poland: experience of the 3-million population region of Lower Silesia.
Matkowski R; Szynglarewicz B
Cancer Epidemiol; 2011 Dec; 35(6):e111-5. PubMed ID: 21840281
[TBL] [Abstract][Full Text] [Related]
11. Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review.
Puliti D; Duffy SW; Miccinesi G; de Koning H; Lynge E; Zappa M; Paci E;
J Med Screen; 2012; 19 Suppl 1():42-56. PubMed ID: 22972810
[TBL] [Abstract][Full Text] [Related]
12. Toward the breast screening balance sheet: cumulative risk of false positives for annual versus biennial mammograms commencing at age 40 or 50.
Winch CJ; Sherman KA; Boyages J
Breast Cancer Res Treat; 2015 Jan; 149(1):211-21. PubMed ID: 25476499
[TBL] [Abstract][Full Text] [Related]
13. The balance sheet of benefits and harms of breast cancer population-based screening in Europe: outcome research, practice and future challenges.
Broeders M; Paci E
Womens Health (Lond); 2015 Nov; 11(6):883-90. PubMed ID: 26619214
[TBL] [Abstract][Full Text] [Related]
14. Estimates of overdiagnosis of invasive breast cancer associated with screening mammography.
Morrell S; Barratt A; Irwig L; Howard K; Biesheuvel C; Armstrong B
Cancer Causes Control; 2010 Feb; 21(2):275-82. PubMed ID: 19894130
[TBL] [Abstract][Full Text] [Related]
15. Balancing the benefits and detriments among women targeted by the Norwegian Breast Cancer Screening Program.
Hofvind S; Román M; Sebuødegård S; Falk RS
J Med Screen; 2016 Dec; 23(4):203-209. PubMed ID: 26940960
[TBL] [Abstract][Full Text] [Related]
16. The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies.
Broeders M; Moss S; Nyström L; Njor S; Jonsson H; Paap E; Massat N; Duffy S; Lynge E; Paci E;
J Med Screen; 2012; 19 Suppl 1():14-25. PubMed ID: 22972807
[TBL] [Abstract][Full Text] [Related]
17. Minority report - false negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis.
Ciatto S; Houssami N; Ambrogetti D; Bonardi R; Collini G; Del Turco MR
Breast Cancer Res Treat; 2007 Sep; 105(1):37-43. PubMed ID: 17115112
[TBL] [Abstract][Full Text] [Related]
18. [Estimation of years of life gained within the pilot screening program of the Ariana area of Tunisia].
Hsairi M; Dridi Y; Ben Abdallah M; Boussen H; Ben Hamida A
Tunis Med; 2009 Jul; 87(7):484-8. PubMed ID: 20063685
[TBL] [Abstract][Full Text] [Related]
19. Mammographic screening of women aged 40 to 49 years. Is it justified?
Feig SA
Obstet Gynecol Clin North Am; 1994 Dec; 21(4):587-606. PubMed ID: 7731636
[TBL] [Abstract][Full Text] [Related]
20. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties.
Duffy SW; Tabár L; Chen HH; Holmqvist M; Yen MF; Abdsalah S; Epstein B; Frodis E; Ljungberg E; Hedborg-Melander C; Sundbom A; Tholin M; Wiege M; Akerlund A; Wu HM; Tung TS; Chiu YH; Chiu CP; Huang CC; Smith RA; Rosén M; Stenbeck M; Holmberg L
Cancer; 2002 Aug; 95(3):458-69. PubMed ID: 12209737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
